Source comparison
TB-500 Dosing Protocols: Research vs. Veterinary Comparison
Veterinary (Equine) 2.5mg twice weekly × 4 weeks 2.5mg once weekly × 4–8 weeks 8–12 weeks Tendon/ligament injury, post-surgical recovery Gold standard. Longest clinical track record, best-documented efficacy in connective tissue repair Human Research (Off-Labe
This comparison does not assign a generated winner or score.
- Veterinary (Equine)
- 2.5mg twice weekly × 4 weeks
- 2.5mg once weekly × 4–8 weeks
- 8–12 weeks
- Tendon/ligament injury, post-surgical recovery
- Gold standard. Longest clinical track record, best-documented efficacy in connective tissue repair
- Human Research (Off-Label)
- 2–2.5mg twice weekly × 4–6 weeks
- 2mg once weekly × 4 weeks
- 8–10 weeks
- Chronic tendinopathy, muscle strain, post-injury recovery
- Most common protocol adapted from veterinary data. Lacks FDA-approved endpoints but widely used in research settings
- Accelerated Protocol
- 5mg twice weekly × 2 weeks
- 2mg once weekly × 2 weeks
- 4 weeks total
- Acute injury within 48 hours of onset
- Higher upfront cost, unproven advantage over standard dosing. Tissue remodeling timelines don't compress proportionally to dose
- Low-Dose Maintenance
- 1mg twice weekly × 6 weeks
- 1mg once weekly × 6 weeks
- 12 weeks total
- Preventative use, minor soft tissue wear
- Subtherapeutic for acute injury. May support general recovery but insufficient for measurable collagen deposition